Connect with us

Tech News

YOUR FUTURE DOCTOR MAY NOT BE HUMAN. THIS IS THE RISE OF AI IN MEDICINE.

Published

on

Diagnosing with “The Stethoscope of the 21st Century”

A new kind of doctor has entered the exam room, but doesn’t have a name. In fact, these doctors don’t even have faces. Artificial intelligence has made its way into hospitals around the world. Those wary of a robot takeover have nothing to fear; the introduction of AI into health care is not necessarily about pitting human minds against machines. AI is in the exam room to expand, sharpen, and at times ease the mind of the physician so that doctors are able to do the same for their patients.

Bertalan Meskó, known better as The Medical Futurist, has called artificial intelligence the “the stethoscope of the 21st century.” His assessment may prove to be even more accurate than he expected. While various techniques and tests give them all the information they need to diagnose and treat patients, physicians are already overburdened with clinical and administrative responsibilities, and sorting through the massive amount of available information is a daunting, if not impossible, task.

That’s where having the 21st century stethoscope could make all the difference.

The applications for AI in medicine go beyond administrative drudge work, though. From powerful diagnostic algorithms to finely-tuned surgical robots, the technology is making its presence known across medical disciplines. Clearly, AI has a place in medicine; what we don’t know yet is its value. To imagine a future in which AI is an established part of a patient’s care team, we’ll first have to better understand how AI measures up to human doctors. How do they compare in terms of accuracy? What specific, or unique, contributions is AI able to make? In what way will AI be most helpful — and could it be potentially harmful — in the practice of medicine? Only once we’ve answered these questions can we begin to predict, then build, the AI-powered future that we want.

AI vs. Human Doctors

Although we are still in the early stages of its development, AI is already just as capable as (if not more capable than) doctors in diagnosing patients. Researchers at the John Radcliffe Hospital in Oxford, England, developed an AI diagnostics system that’s more accurate than doctors at diagnosing heart disease, at least 80 percent of the time. At Harvard University, researchers created a “smart” microscope that can detect potentially lethal blood infections: the AI-assisted tool was trained on a series of 100,000 images garnered from 25,000 slides treated with dye to make the bacteria more visible. The AI system can already sort those bacteria with a 95 percent accuracy rate. A study from Showa University in Yokohama, Japan revealed that a new computer-aided endoscopic system can reveal signs of potentially cancerous growths in the colon with 94 percent sensitivity, 79 percent specificity, and 86 percent accuracy.

In some cases, researchers are also finding that AI can outperform human physicians in diagnostic challenges that require a quick judgment call, such as determining if a lesion is cancerous. In one study, published December 2017 in JAMA, deep learning algorithms were able better diagnose metastatic breast cancer than human radiologists when under a time crunch. While human radiologists may do well when they have unrestricted time to review cases, in the real world (especially in high-volume, quick-turnaround environments like emergency rooms) a rapid diagnosis could make the difference between life and death for patients.

Then, of course, there’s IBM’s Watson: When challenged to glean meaningful insights from the genetic data of tumor cells, human experts took about 160 hours to review and provide treatment recommendations based on their findings. Watson took just ten minutes to deliver the same kind of actionable advice. Google recently announced an open-source version of DeepVariant, the company’s AI tool for parsing genetic data, which was the most accurate tool of its kind in last year’s precisionFDA Truth Challenge.

With AI in medicine, doctors will have to spend less time doing this. Image Credit: National Cancer Institute via Wikimedia Commons

AI is also better than humans at predicting health events before they happen. In April, researchers from the University of Nottingham published a study that showed that, trained on extensive data from 378,256 patients, a self-taught AI predicted 7.6 percent more cardiovascular events in patients than the current standard of care. To put that figure in perspective, the researchers wrote: “In the test sample of about 83,000 records, that amounts to 355 additional patients whose lives could have been saved.” Perhaps most notably, the neural network also had 1.6 percent fewer “false alarms” — cases in which the risk was overestimated, possibly leading to patients having unnecessary procedures or treatments, many of which are very risky.

AI is perhaps most useful for making sense of huge amounts of data that would be overwhelming to humans. That’s exactly what’s needed in the growing field of precision medicine. Hoping to fill that gap is The Human Diagnosis Project (Human Dx), which is combining machine learning with doctors’ real-life experience. The organization is compiling input from 7,500 doctors and 500 medical institutions in more than 80 countries in order to develop a system that anyone — patient, doctor, organization, device developer, or researcher — can access in order to make more informed clinical decisions.

“You have to design these things with an end user in mind.”

Shantanu Nundy, the Director of the Human Diagnosis Project Nonprofit, told Futurism that, when it comes to developing technology in any industry, the AI should be seamlessly integrated into its function. “You have to design these things with an end user in mind. People use Netflix, but it’s not like ‘AI for watching movies,’ right? People use Amazon, but it’s not like ‘AI for shopping.’”

In other words, if the tech is designed well and implemented in a way that people find useful, people don’t even realize they’re using AI at all.

For open-minded, forward-thinking clinicians, the immediate appeal of projects like Human Dx is that it would, counterintuitively, allow them to spend less time engaged with technology. “It’s been well-documented that over 50 percent of our time now is in front of a screen,” Nundy, who is also a practicing physician in the D.C. area, told Futurism. AI can give doctors some of that time back by allowing them to offload some of the administrative burdens, like documentation.

In this respect, when it comes to healthcare, AI isn’t necessarily about replacing doctors, but optimizing and improving their abilities.

Mental Health Care with a Human Touch

“I see the value of AI today as augmenting humans, not as replacing humans,” Skyler Place, chief behavioral science officer in the mobile health division at Cogito, a Boston-based AI and behavioral analytics company, told Futurism.

Cogito has been using AI-powered voice recognition and analysis to improve customer service interactions across many industries. The company’s foray into healthcare has come in the form of Cogito Companion, a mental health app that tracks a patient’s behavior.

Cotigo Companion. Image Credit: Cotigo

The app monitors a patient’s phone for both active and passive behavior signals, such as location data that could indicate a patient hasn’t left their home for several days or communication logs that indicate they haven’t texted or spoken on the phone to anyone for several weeks (the company claims the app only knows if a patient is using their phone to call or text — it doesn’t track who a user is calling or what’s being said). The patient’s care team can monitor the subsequent reports for signs that, in turn, may indicate changes to the patient’s overall mental health.

Cogito has teamed up with several healthcare systems throughout the country to test the app, which has found a particular niche in the veteran population. Veterans are at high risk for social isolation and may be reluctant to engage with the healthcare system, particularly mental health resources, often because of social stigma. “What we’ve found is that the app is acting as a way to build trust, in a way to drive engagement in healthcare more broadly,” Place said, adding that the app “effectively acts as a primer for behavioral change,” which seems to help veterans feel empowered and willing to engage with mental health services.

Here’s where the AI comes in: the app also uses machine learning algorithms to analyze “audio check ins” — voice recordings the patient makes (somewhat akin to an audio diary). The algorithms are designed to pick up on emotional cues, just as two humans talking would. “We’re able to build algorithms that match the patterns in how people are speaking, such as energy, intonation, the dynamism or flow in a conversation,” Place explained.

From there, humans train the algorithm to learn what “trustworthy” or “competence” sound like, to identify the voice of someone who is depressed, or the differences in the voice of a bipolar patient when they’re manic versus when they’re depressed. While the app provides real-time information for the patient to track their mood, the information also helps clinicians track their patient’s progress over time.

At Cogito, Place has seen the capacity of artificial intelligence to help us “understand the human aspects of conversations and the human aspects of mental health.”

Understanding, though, is just the first step. The ultimate goal is finding a treatment that works, and that’s where doctors currently shine in relation to mental health issues. But where do robots stand when it comes to things that are more hands-on?

Under The (Robotic) Knife

Over the last couple of decades, one of the most headline-making applications for AI in medicine has been the development of surgical robots.

In most cases to date, surgical robots (the da Vinci is the most well-known) function as an extension of the human surgeon, who controls the device from a nearby console. One of the more ambitious procedures, claimed to be a world-first, took place in Montreal in 2010. It was the first in-tandem performance of both a surgical robot as well as a robot anesthesiologist (cheekily named McSleepy); data gathered on the procedure reflects the impressive performance of these robotic doctors.

In 2015, more than a decade after the first surgical robots entered the operating room, MIT performed a retrospective analysis of FDA data to assess the safety of robotic surgery. There were 144 patient deaths and 1,391 patient injuries reported during the period of study, which were mainly caused by technical difficulties or device malfunctions. The report noted that “despite a relatively high number of reports, the vast majority of procedures were successful and did not involve any problems.” But the number of events in more complex surgical areas (like cardiothoracic surgery) were “significantly higher” than in areas like gynecology and general surgery.

Surgical robot. Image Credit: Getty Images

The takeaway would seem to be that, while robotic surgery can perform well in some specialties, the more complex surgeries are best left to human surgeons — at least for now. But this could change quickly, and as surgical robots are able to operate more independently from human surgeons, it will become harder to know who to blame when something goes wrong.

Can a patient sue a robot for malpractice? As the technology is still relatively new, litigation in such cases constitutes something of a legal gray area. Traditionally, experts consider medical malpractice to be the result of negligence on the part of the physician or the violation of a defined standard of care. The concept of negligence, though, implies an awareness that AI inherently lacks, and while it’s conceivable that robots could be held to performance standards of some kind, those standards would need to exist.

So if not the robot, who, or what, takes the blame? Can a patient’s family hold the human surgeon overseeing the robot accountable? Or should the company that manufactured the robot shoulder the responsibility? The specific engineer who designed it? This is a question that, at present, has no clear answer — but it will need to be addressed sooner rather than later.

Building, Not Predicting, the Future

In the years to come, AI’s role in medicine will only grow: In a report prepared by Accenture Consulting, the market value of AI in medicine in 2014 was found to be $600 million. By 2021, that figure is projected to reach $6.6 billion.

The industry may be booming, but we shouldn’t integrate AI hurriedly or haphazardly. That’s in part because things that are logical to humans are not to machines. Take, for example, an AI trained to determine if skin lesions were potentially cancerous. Dermatologists often use rulers to measure the lesions that they suspect to be cancerous. When the AI was trained on those biopsy images, it was more likely to say a lesion was cancerous if a ruler was present in the image, according to The Daily Beast.

Algorithms may also inherit our biases, in part because there’s a lack of diversity in the materials used to train AI. In medicine or not, the data the machines are trained on is largely determined by who is conducting the research and where it’s being done. White men still dominate the fields of clinical and academic research, and they also make up most of the patients who participate in clinical trials.

A tenet of medical decision-making is whether the benefits of a procedure or treatment outweigh the risks. When considering whether or not AI is ready to be on equal footing with a human surgeon in the operating room, a little risk-benefit and equality analysis will go a long way.

“I think if you build [the technology] with the right stakeholders at the table, and you invest the extra effort to be really inclusive in how you do that, then I think we can change the future,” Nundy, of Human Dx, said. “We’re trying to actually shape what the future holds.”

Though sometimes we fear that robots are leading the charge towards integrating AI in medicine, humans are the ones having these conversations and, ultimately, driving the change. We decide where AI should be applied and what’s best left done the old-fashioned way. Instead of trying to predict what a doctor’s visit will be like in 20 years, physicians can use AI as a tool to start building the future they want — the future that’s best for them and their patients — today.

 

 

 

 

 

 

Source: https://futurism.com/ai-medicine-doctor/

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Tech News

Paypal to allow users to buy, hold and sell four cryptocurrencies

Published

on

By

Bitcoin is up $400 to $12,296 today. Part of the reason is that Paypal hass received a conditional bitlicence from the New York State Department of Financial Services and will launch a service for users to be able to buy, hold and sell cryptocurrency.
In the release the company said it “signaled its plans to significantly increase cryptocurrency’s utility by making it available as a funding source for purchases at its 26 million merchants worldwide.”
The company is introducing the ability to buy, hold and sell select cryptocurrencies, initially featuring Bitcoin, Ethereum, Bitcoin Cash and Litecoin, directly within the PayPal digital wallet. The service will be available to PayPal account holders in the U.S. in the coming weeks.
“The shift to digital forms of currencies is inevitable, bringing with it clear advantages in terms of financial inclusion and access; efficiency, speed and resilience of the payments system; and the ability for governments to disburse funds to citizens quickly,” said Dan Schulman, president and CEO, PayPal.
“Our global reach, digital payments expertise, two-sided network, and rigorous security and compliance controls provide us with the opportunity, and the responsibility, to help facilitate the understanding, redemption and interoperability of these new instruments of exchange. We are eager to work with central banks and regulators around the world to offer our support, and to meaningfully contribute to shaping the role that digital currencies will play in the future of global finance and commerce.”

This is great news for crypto but I’m told it shouldn’t have been entirely unexpected In June, there was a report that Paypal was working on direct crypto sales.

Source: https://www.forexlive.com/Cryptocurrency/!/paypal-to-enable-users-to-buy-hold-and-sell-cryptocurrencies-20201021

Continue Reading

Tech News

Nokia awarded contract to build 4G network on the moon

Published

on

By

Nokia has been awarded a contract to establish a 4G network on the moon. The contract is one of several that NASA is awarding to companies as it plans a return to the moon.

The $14.1 million contract was given to Nokia’s US subsidiary and is a small part of the $370 million total awarded to companies such as SpaceX. The cellular service will allow astronauts, rovers, lunar landers, and habitats to communicate with one another according to Jim Reuter, the Associate Administrator for NASA’s Space.

Nokia Logo

The 4G network that Nokia will build will be miles superior to the form of communication that was used during the early missions to the moon.

This is not Nokia’s first attempt to launch an LTE network on the moon. It planned to do so in 2018 in collaboration with PTScientists, a German space firm, and Vodafone UK to launch an LTE network at the site of the Apollo 17 landing but the plan never came to fruition.

Source: https://www.gizmochina.com/2020/10/18/nokia-awarded-contract-to-build-4g-network-on-the-moon/

Continue Reading

Tech News

Stripe acquires Nigeria’s Paystack for $200M+ to expand into the African continent

Published

on

By

When Stripe  announced earlier this year that it had picked up another $600 million in funding, it said one big reason for the funding was to expand its API-based payments services into more geographies. Today the company is coming good on that plan in the form of some M&A.

Stripe is acquiring Paystack, a startup out of Lagos, Nigeria that, like Stripe, provides a quick way to integrate payments services into an online or offline transaction by way of an API. (We and others have referred to it in the past as “the Stripe of Africa.”)

Paystack  currently has around 60,000 customers, including small businesses, larger corporates, fintechs, educational institutions and online betting companies, and the plan will be for it to continue operating independently, the companies said.

Terms of the deal are not being disclosed, but sources close to it confirm that it’s over $200 million. That makes this the biggest startup acquisition to date to come out of Nigeria, as well as Stripe’s biggest acquisition to date anywhere. (Sendwave, acquired by WorldRemit in a $500 million deal in August, is based out of Kenya.)

It’s also a notable shift in Stripe’s strategy as it continues to mature: Typically, it has only acquired smaller companies to expand its technology stack, rather than its global footprint.

The deal underscores two interesting points about Stripe, now valued at $36 billion and regularly tipped as an IPO candidate. (Note: It has never commented on those plans up to now.) First is how it is doubling down on geographic expansion: Even before this news, it had added 17 countries to its platform in the last 18 months, along with progressive feature expansion. And second is how Stripe is putting a bet on the emerging markets of Africa specifically in the future of its own growth.

“There is enormous opportunity,” said Patrick Collison, Stripe’s co-founder and CEO, in an interview with TechCrunch. “In absolute numbers, Africa may be smaller right now than other regions, but online commerce will grow about 30% every year. And even with wider global declines, online shoppers are growing twice as fast. Stripe thinks on a longer time horizon than others because we are an infrastructure company. We are thinking of what the world will look like in 2040-2050.”

For Paystack, the deal will give the company a lot more fuel (that is, investment) to build out further in Nigeria and expand to other markets, CEO Shola Akinlade said in an interview.

“Paystack was not for sale when Stripe approached us,” said Akinlade, who co-founded the company with Ezra Olubi (who is the CTO). “For us, it’s about the mission. I’m driven by the mission to accelerate payments on the continent, and I am convinced that Stripe will help us get there faster. It is a very natural move.”

Paystack had been on Stripe’s radar for some time prior to acquiring it. Like its U.S. counterpart, the Nigerian startup went through Y Combinator — that was in 2016, and it was actually the first-ever startup out of Nigeria to get into the world-famous incubator. Then, in 2018, Stripe led an $8 million funding round for Paystack, with others participating, including Visa and Tencent. (And for the record, Akinlade said that Visa and Tencent had not approached it for acquisition. Both have been regular investors in startups on the continent.)

In the last several years, Stripe has made a number of investments into startups building technology or businesses in areas where Stripe has yet to move. This year, those investments have included backing an investment in universal checkout service Fast, and backing the Philippines-based payment platform PayMongo.

Collison said that while acquiring Paystack after investing in it was a big move for the company, people also shouldn’t read too much into it in terms of Stripe’s bigger acquisition policy.

“When we invest in startups we’re not trying to tie them up with complicated strategic investments,” Collison said. “We try to understand the broader ecosystem, and keep our eyes pointed outwards and see where we can help.”

That is to say, there are no plans to acquire other regional companies or other operations simply to expand Stripe’s footprint, with the interest in Paystack being about how well they’d built the company, not just where they are located.

“A lot of companies have been, let’s say, heavily influenced by Stripe,” Collison said, raising his eyebrows a little. “But with Paystack, clearly they’ve put a lot of original thinking into how to do things better. There are some details of Stripe that we consider mistakes, but we can see that Paystack ‘gets it,’ it’s clear from the site and from the product sensibilities, and that has nothing to do with them being in Africa or African.”

Stripe, with its business firmly in the world of digital transactions, already has a strong line in the detection and prevention of fraud and other financial crimes. It has developed an extensive platform of fraud protection tools, but even with that, incidents can slip through the cracks. Just last month, Stripe was ordered to pay $120,000 in a case in Massachusetts after failing to protect users in a $15 million cryptocurrency scam.

Now, bringing on a business from Nigeria could give the company a different kind of risk exposure. Nigeria is the biggest economy in Africa, but it is also one of the more corrupt on the continent, according to research from Transparency International.

And related to that, it also has a very contentious approach to law and order. Nigeria has been embroiled in protests in the last week with demonstrators calling for the disbanding of the country’s Special Anti-Robbery Squad, after multiple accusations of brutality, including extrajudicial killings, extortion and torture. In fact, Stripe and Paystack postponed the original announcement in part because of the current situation in the country.

But while those troubles continue to be worked through (and hopefully eventually resolved, by way of government reform in response to demonstrators’ demands), Paystack’s acquisition is a notable foil to those themes. It points to how talented people in the region are identifying problems in the market and building technology to help fix them, as a way of improving how people can transact, and in turn, economic outcomes more generally.

The company got its start back when Akinlade, for fun (!) built a quick way of integrating a card transaction into a web page, and it was the simplicity of how it worked that spurred him and his co-founder to think of how to develop that into something others could use. That became the germination of the idea that eventually landed them at YC and in the scope of Stripe.

“We’re still very early in the Paystack payments ecosystem, which is super broken,” said Akinlade. The company today provides a payments API, and it makes revenue every time a transaction is made using it. He wouldn’t talk about what else is on Paystack’s radar, but when you consider Stripe’s own product trajectory as a template, there is a wide range of accounting, fraud, card, cash advance and other services to meet business needs that could be built around that to expand the business. “Most of what we will be building in Africa has not been built yet.”

Last month, at Disrupt, we interviewed another successful entrepreneur in the country, Tunde Kehinde, who wisely noted that more exits of promising startups — either by going public or getting acquired — will help lift up the whole ecosystem. In that regard, Stripe’s move is a vote of confidence not just for the potential of the region, but for those putting in the efforts to build tech and continue improving outcomes for everyone.

Source: https://techcrunch.com/2020/10/15/stripe-acquires-nigerias-paystack-for-200m-to-expand-into-the-african-continent/?tpcc=ECTW2020

Continue Reading
Advertisement

Trending

Copyright © 2020 Inventrium Magazine

%d bloggers like this: